P. 1
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018

|Views: 1|Likes:
Published by aarkstor

More info:

Published by: aarkstor on Jun 28, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOCX, PDF, TXT or read online from Scribd
See more
See less

12/23/2012

pdf

text

original

Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary “Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Anti-Obesity Therapeutics market. The report identifies the key trends shaping and driving the global Anti-Obesity Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Anti-Obesity Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Company team of industry experts. Scope The report provides information on the key drivers and challenges of the Anti-Obesity Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Anti-Obesity Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Anti-Obesity Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Anti-Obesity Therapeutics market. - Analysis of key recent licensing and partnership agreements in Anti-Obesity Therapeutics market Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Anti-Obesity Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Anti-Obesity Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What the next big thing in the global Anti-Obesity Therapeutics market landscape? – Identify, understand and capitalize. 1.1 List of Tables 5 1.2 List of Figures 6 2 Anti-Obesity Therapeutics - Introduction 7 2.1 Overview 7 2.2 Epidemiology 7 2.3 Etiology 8 2.3.1 Role of Energy Expenditure in the Development of Obesity 8 2.3.2 Central Mechanism Regulate Energy Homeostasis 8 2.3.3 Psychological Factors 9 2.3.4 Endocrine Factors 9

2.3.5 Genes and Environmental Factors 9 2.4 Symptoms 9 2.5 Diagnosis 10 2.6 Pathophysiology 11 2.6.1 Role of Genetics in Obesity 12 2.7 Treatment 14 2.7.1 Lifestyle Modification 14 2.7.2 Dietary Interventions 14 2.7.3 Behavioral Therapy 14 2.7.4 Pharmacotherapy 14 2.7.5 Surgical Interventions 15 2.8 GlobalData Pipeline Report Guidance 16 3 Anti-Obesity Therapeutics - Market Characterization 17 3.1 Anti-Obesity Therapeutics Market Size - Global (2005-2010) 17 3.2 Anti-Obesity Therapeutics Market Forecast - Global (2010-2018) 18 3.3 Anti-Obesity Therapeutics Market Size - The US (2005-2010) 19 3.4 Anti-Obesity Therapeutics Market Forecast - The US (2010-2018) 20 3.5 Anti-Obesity Therapeutics Market Size - France (2005-2010) 21 3.6 Anti-Obesity Therapeutics Market Forecast - France (2010-2018) 22 3.7 Anti-Obesity Therapeutics Market Size - Germany (2005-2010) 23 3.8 Anti-Obesity Therapeutics Market Forecast - Germany (2010-2018) 24 3.9 Anti-Obesity Therapeutics Market Size - Italy (2005-2010) 25 3.10 Anti-Obesity Therapeutics Market Forecast - Italy (2010-2018) 26 3.11 Anti-Obesity Therapeutics Market Size - Spain (2005-2010) 27 3.12 Anti-Obesity Therapeutics Market Forecast - Spain (2010-2018) 28 3.13 Anti-Obesity Therapeutics Market Size - The UK (2005-2010) 29 3.14 Anti-Obesity Therapeutics Market Forecast - The UK (2010-2018) 30 3.15 Anti-Obesity Therapeutics Market Size - Japan (2005-2010) 31 3.16 Anti-Obesity Therapeutics Market Forecast - Japan (2010-2018) 32 3.17 Drivers and Barriers for the Anti-Obesity Therapeutics Market 33 3.17.1 Anti-Obesity Therapeutics Market Drivers 33 3.17.2 Anti-Obesity Therapeutics Market Barriers 33 3.18 Opportunity and Unmet Need 34 3.19 Key Takeaway 35 4 Anti-Obesity Therapeutics - Competitive Assessment 36 4.1 Overview 36 4.2 Strategic Competitor Assessment 36 4.3 Product Profile for the Major Marketed Products in the Anti-Obesity Therapeutics 37 4.3.1 Xenical (orlistat) 37 4.4 Key Takeaway 38 5 Anti-Obesity Therapeutics - Pipeline Assessment 39 5.1 Overview 39 5.2 Strategic Pipeline Assessment 39 5.3 Anti-Obesity Therapeutics Market - Pipeline Assessment by Phase of Development 39 5.3.1 Anti-Obesity Therapeutics - Filed and Phase III Pipeline 39 5.3.2 Anti-Obesity Therapeutics - Phase II Pipeline 40 5.3.3 Anti-Obesity Therapeutics - Phase I Pipeline 41 5.3.4 Anti-Obesity Therapeutics - Preclinical Pipeline 42 5.3.5 Anti-Obesity Therapeutics - Discovery Pipeline 43 5.4 Anti-Obesity Therapeutics - Pipeline by Mechanism of Action 44 5.5 Technology Trends Analytical Framework 46 5.6 Anti-Obesity Therapeutics Market - Most Promising Drugs Under Clinical Development 47 5.7 Most Promising Drug Profiles 48 5.7.1 Contrave (bupropion SR/naltrexone) 48 5.7.2 Cametor (cetilistat) 49 5.7.3 Qnexa 49 5.7.4 Lorqess (lorcaserin hydrochloride) 50 5.7.5 Victoza (liraglutide) 51 5.8 Key Takeaway 51 6 Anti-Obesity Therapeutics - Clinical Trials Mapping 52 6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 52 6.2 Clinical Trials by Phase of Clinical Development 53 6.3 Clinical Trials by Trial Status 54 6.4 Prominent Sponsors 55

6.5 Brief Profiles of Top Ten Companies Participating in Therapeutics Clinical Trials 57 7 Anti-Obesity Therapeutics - Strategic Assessment 58 7.1 Key Events Impacting the Future Market 58 7.2 Future Market Competition Scenario 59 8 Anti-Obesity Therapeutics - Future Players 60 8.1 Introduction 60 8.2 Company Profiles 60 8.2.1 Arena Pharmaceuticals 60 8.2.2 VIVUS, Inc 61 8.2.3 Orexigen Therapeutics 62 8.2.4 Norgine Limited 62 8.2.5 Novo Nordisk 63 8.2.6 Tabular Presentation Details of Other Companies in the Pipeline 64 8.2.7 Key Takeaway 65 9 Anti-Obesity Therapeutics - Licensing and Partnership Deals, 2011 66 10 Anti-Obesity Therapeutics - Appendix 75 10.1 Market Definitions 75 10.2 Acronyms 75 10.3 Methodology 76 10.3.1 Coverage 77 10.3.2 Secondary Research 77 10.3.3 Forecasting 77 10.3.4 Primary Research 79 10.3.5 Expert Panel Validation 80 10.4 Contact Us 80 10.5 Disclaimer 80 10.6 Bibliography 80 1.1 List of Tables Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table 1: Obesity - Epidemiology 7 2: Uncoupling Proteins in Humans 8 3: Anti-Obesity Therapeutics - Classification of Underweight, Obese and Overweight 10 4: Anti-Obesity Therapeutics Major Markets, Global, Revenue ($m), 2005-2010 17 5: Anti-Obesity Therapeutics Major Markets, Global, Forecast ($m), 2010-2018 18 6: Anti-Obesity Therapeutics Market, The US, Revenue ($m), 2005-2010 19 7: Anti-Obesity Therapeutics Market, The US, Forecast ($m), 2010-2018 20 8: Anti-Obesity Therapeutics Market, France, Revenue ($m), 2005-2010 21 9: Anti-Obesity Therapeutics Market, France, Forecast ($m), 2010-2018 22 10: Anti-Obesity Therapeutics Market, Germany, Revenue ($m), 2005-2010 23 11: Anti-Obesity Therapeutics Market, Germany, Forecast ($m), 2010-2018 24 12: Anti-Obesity Therapeutics Market, Italy, Revenue ($m), 2005-2010 25 13: Anti-Obesity Therapeutics Market, Italy, Forecast ($m), 2010-2018 26 14: Anti-Obesity Therapeutics Market, Spain, Revenue ($m), 2005-2010 27 15: Anti-Obesity Therapeutics Market, Spain, Forecast ($m), 2010-2018 28 16: Anti-Obesity Therapeutics Market, The UK, Revenue ($m), 2005-2010 29 17: Anti-Obesity Therapeutics Market, The UK, Forecast ($m), 2010-2018 30 18: Anti-Obesity Therapeutics Market, Japan, Revenue ($m), 2005-2010 31 19: Anti-Obesity Therapeutics Market, Japan, Forecast ($m), 2010-2018 32 20: Anti-Obesity Therapeutics - Filed and Phase III Pipeline, 2011 39 21: Anti-Obesity Therapeutics - Phase II Pipeline, 2011 40 22: Anti-Obesity Therapeutics - Phase I Pipeline, 2011 41 23: Anti-Obesity Therapeutics - Preclinical Pipeline, 2011 42 24: Anti-Obesity Therapeutics - Discovery Pipeline, 2011 43 25: Anti-Obesity Therapeutics - Most Promising Drugs Under Clinical Development, 2011 47 26: Anti-Obesity Therapeutics, Major Markets - Clinical Trials by Country, 2011 52 27: Anti-Obesity Therapeutics, Major Markets - Clinical Trials by Phase, 2011 53 28: Anti-Obesity Therapeutics, Major Markets - Clinical Trials by Development Status, 2011 54 29: Anti-Obesity Therapeutics, Major Markets - Overall Sponsors, 2011 55 30: Anti-Obesity Therapeutics, Major Markets - Prominent Sponsors, 2011 56 31: Anti-Obesity Therapeutics, Major Markets - Companies Participating in Clinical Trials, 2011 57 32: Arena Pharmaceuticals Pipeline Products, 2011 61 33: VIVUS, Inc Pipeline Products, 2011 61

Table Table Table Table

34: 35: 36: 37:

Orexigen Therapeutics, Pipeline Products, 2011 62 Norgine Limited, Pipeline Products, 2011 62 Novo Nordisk Pipeline Products, 2011 63 Description of Other Companies in the Pipeline, 2011 64

Table 38: Anti-Obesity Therapeutics, Global, Deals, 2011 66 1.2 List of Figures Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure 1: Representation of Peptides Secreted by Gut and Adipose Controls Energy Balance 13 2: Treatment and Management of Obesity 15 3: Anti-Obesity Therapeutics Major Market, Global, Revenue ($m), 2005-2010 17 4: Anti-Obesity Therapeutics Major Market, Global, Forecast ($m), 2010-2018 18 5: Anti-Obesity Therapeutics Market, The US, Revenue ($m), 2005-2010 19 6: Anti-Obesity Therapeutics Market, The US, Forecast ($m), 2010-2018 20 7: Anti-Obesity Therapeutics Market, France, Revenue ($m), 2005-2010 21 8: Anti-Obesity Therapeutics Market, France, Forecast ($m), 2010-2018 22 9: Anti-Obesity Therapeutics Market, Germany, Revenue ($m), 2005-2010 23 10: Anti-Obesity Therapeutics Market, Germany, Forecast ($m), 2010-2018 24 11: Anti-Obesity Therapeutics Market, Italy, Revenue ($m), 2005-2010 25 12: Anti-Obesity Therapeutics Market, Italy, Forecast ($m), 2010-2018 26 13: Anti-Obesity Therapeutics Market, Spain, Revenue ($m), 2005-2010 27 14: Anti-Obesity Therapeutics Market, Spain, Forecast ($m), 2010-2018 28 15: Anti-Obesity Therapeutics Market, The UK, Revenue ($m), 2005-2010 29 16: Anti-Obesity Therapeutics Market, The UK, Forecast ($m), 2010-2018 30 17: Anti-Obesity Therapeutics Market, Japan, Revenue ($m), 2005-2010 31 18: Anti-Obesity Therapeutics Market, Japan, Forecast ($m), 2010-2018 32 19: Opportunity and Unmet Need in the Anti-Obesity Therapeutics Market, 2011 34 20: Anti-Obesity Therapeutics - Strategic Competitor Assessment, 2011 36 21: Anti-Obesity Therapeutics - Pipeline by Mechanism of Action, 2011 44 22: Anti-Obesity Therapeutics - Pipeline by Phase of Development, 2011 45 23: Anti-Obesity Therapeutics - Technology Trends Analytics Framework, 2011 46 24: Anti-Obesity Therapeutics - Technology Trends Analytics Framework Description, 2011 47 25: Anti-Obeisty Therapeutics, Major Markets - Clinical Trials by Country, 2011 52 26: Anti-Obesity Therapeutics, Major Markets - Clinical Trials by Phase, 2011 53 27: Anti-Obesity Therapeutics, Major Markets - Clinical Trials by Development Status, 2011 54 28: Anti-Obesity Therapeutics, Major markets - Overall Sponsors, 2011 55 29: Anti-Obesity Therapeutics, Major markets - Prominent Sponsors, 2011 56 30: Anti-Obesity Therapeutics, Major markets - Clinical Trials of Top Ten Companies by Phase, 2011 57 31: Anti-Obesity Therapeutics Market, Drivers and Barriers 2011 58 32: Implications for Future Market Competition in the Anti-Obesity Therapeutics Market, 2011 59 33: Anti-Obesity Therapeutics Market - Pipeline by Company, 2011 60

Figure 34: GlobalData Market Forecasting Model 79 Company Mentioned: Arena Pharmaceuticals VIVUS, Inc Orexigen Therapeutics Norgine Limited Novo Nordisk For more information, please visit:

http://www.aarkstore.com/reports/Anti-Obesity-Therapeutics-Pipeline-Assessment-and-MarketForecasts-to-2018-198827.html
Or email us at contact@aarkstore.com or call +918149852585 More Reports

Solar Module Recycling - A Necessary Step to Maximize Environmental Benefits of Solar PV Industry Geothermal Power - Global Market Size, Technology Analysis, Regulations and Key Country Analysis to 2020 Advanced Clean Energy Storage Devices - Global Market Size, Market Analysis by Major Storage Device, and Competitive Landscape to 2020 Thin-Film PV - Global Market Size, Price Analysis, Regulations and Competitive Landscape to 2020 Wind Operations & Maintenance (O&M) Market - Global Market Size, Share by Component, Competitive Landscape and Key Country Analysis to 2020 Compact Fluorescent Lamp (CFL) Market - Global Market Size, Price Analysis, Regulations and Key Countries Analysis to 2020 Biofuels (Biodiesel and Bioethanol) Market - Global Production, Regulations, Export-Import Analysis and Key Country Analysis to 2020 Wind Repowering - Capacity, Generation and Cost-Benefit Analysis to 2020 Oil and Gas Capital Expenditure Outlook, 2012 Offshore Oil and Gas Developments in Asia-Pacific - Burgeoning Energy Demand Drives Exploration and Production Activities Strategic Pipelines Set to Change Geopolitical and Demand Supply Paradigm in the Global Oil and Gas Industry Coal Seam Gas (CSG/CBM) in Asia, 2011 - Market Analysis, Investment Scenario, Competitive Landscape and Production Forecasts to 2015 Refining Industry in Asia-Pacific - Market Analysis, Competitive Landscape and Capacity Forecasts to 2016 Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2015 Bakken Shale, 2011 - Oil Shale Market Analysis and Forecasts to 2020 Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020 Niobrara Shale in the US, 2012 - Oil Shale Market Analysis and Forecasts to 2020 Utica Shale, 2012 - Oil and Gas Market Analysis and Forecasts to 2020 Haynesville Shale in the US, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Montney Shale in Canada, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Nuclear Condensate and Feed Water Pumps - Global Market Size, Pricing, Regional Analysis and Competitive Landscape to 2020 Nuclear Moisture Separator Reheaters Market - Global Market Size, Pricing Analysis, Regional Analysis and Competitive Landscape to 2020 Plant Life Extension (PLEX) and Plant Life Management (PLIM) for Nuclear Reactors - Global Landscape Analysis to 2020 Phase Shifting Transformers for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Steam Turbines in Asia-Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Shunt Reactor for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Power Boilers in Asia Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines in BRIC (Brazil, Russia, India and China) - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Heat Recovery Steam Generator (HRSG) Market in Asia-Pacific Region - Market Size, Pricing Analysis, Equipment Market Share and Competitive Landscape Analysis to 2020 High Voltage Direct Current (HVDC) Cables - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines for Thermal Power - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Wireless Communication Modules for Smart Meters - Market Analysis and Forecasts to 2020 Smart Grid Vendor Landscape Analysis - Strategic Activity Analysis and Outlook to 2015 In-Home Displays for Energy Management - Market Analysis and Forecasts to 2020 Smart Grid Market and Technology Outlook - Industry Trends and Competitive Analysis Smart Grid Landscape in Europe - Market Size, Key Issues, Regulations, Investment Analysis and Outlook to 2020 Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018

Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Rhabdomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Lyme Disease - Pipeline Assessment and Market Forecasts to 2018 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Graves’ Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenström’s Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Electrosurgical Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Compression Therapy - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Wound Closure Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Wound Closure Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Ostomy Drainage Bags Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Flexible Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Rigid Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Capsule Endoscope Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Aarkstore Enterprise Tel : +912227453309 Mobile No: +919272852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com http://www.facebook.com/aarkstoreenterprise http://in.linkedin.com/in/aarkstore Blog: http://blogs.aarkstore.com/ Follow us on twitter: http://twitter.com/aarkstoredotcom

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->